Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-11-07Systems Oncology Approach to Optimize Ovarian Cancer Treatment
-
CLINICAL_TRIALS study record update · 2023-11-07Shanghai Ovarian Cancer and Family Care Project
-
CLINICAL_TRIALS study record update · 2023-11-07New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-10-31Validation of Doppler Ultrasound, CT Parameters Versus Laparoscopic Scoring in Assessment of Suspicious Ovarian Malignancy
-
CLINICAL_TRIALS study record update · 2023-10-30A Phase Ib, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Ipatasertib in Combination With Rucaparib in Patients With Advanced Breast, Ovarian, or Prostate Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-10-27Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice
-
CLINICAL_TRIALS study record update · 2023-10-19First-in-Human, Phase 1 Study of AMT-151, an Anti-Folate Receptor Alpha Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2023-10-12BrUOG 390: Neoadjuvant Treatment With Talazoparib for Women With Newly Diagnosed, Advanced Ovarian Cancer Associated With a Mutation in BRCA1 or BRCA2 (mBRCA)
-
CLINICAL_TRIALS study record update · 2023-10-10A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2023-10-05A Phase II Trial of Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-10-05Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-10-02An Open, Multicenter, Exploratory Clinical Study of Fluzoparib in Combination With Bevacizumab for Maintenance Therapy After First-line Platinum-containing Chemotherapy in BRCA Wild-type Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-09-28To Compare the Effects of Intraoperative Use of Intravenous Anesthetics Propofol and Inhaled Anesthetics Sevoflurane on the Prognosis of Patients Undergoing Surgery for Primary Brain, Liver, Lung, and Ovarian Cancer Tumors and the Investigation of Its Mechanism of Action
-
CLINICAL_TRIALS study record update · 2023-09-28A Phase 1/2a Open-Label, Dose-Escalation/Dose-Expansion Safety, Tolerability and Pharmacokinetic Study of IMX-110 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-09-21A Phase I, Open-Label, Multicenter Study of FT536 as Monotherapy and in Combination With Monoclonal Antibodies in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-09-15Phase I Active Immunotherapy Trial With a Combination of Two Chimeric (Trastuzumab-like and Pertuzumab-like)Human Epidermal Growth Factor Receptor 2 (HER-2) B Cell Peptide Vaccine Emulsified in ISA 720 and Nor-MDP Adjuvant in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-09-15Factors Affecting the Prognosis of Early Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-09-15A Phase I Dose Escalation Safety and Feasibility Study of WT1-Specific T Cells for the Treatment of Patients With Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Carcinomas
-
CLINICAL_TRIALS study record update · 2023-09-14Non-interventional Study to Collect Real-world Patient-Reported Outcomes Data in Platinum-Sensitive Relapsed Ovarian Cancer Patients With Long-Term Use of Niraparib
-
CLINICAL_TRIALS study record update · 2023-09-13A Prospective, Observational Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
-
CLINICAL_TRIALS study record update · 2023-09-11An Early Phase Randomized Trial of APX005M in BRCAwt Patients With Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2023-09-06Randomized Double Blind Placebo-controlled Phase II Trial of Vargatef® (Nintedanib) in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Adenocarcinoma of the Ovary, the Fallopian Tube or Serous Adenocarcinoma of the Peritoneum
-
CLINICAL_TRIALS study record update · 2023-09-06Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum
-
CLINICAL_TRIALS study record update · 2023-09-06A Randomized Phase II Study of Pazopanib and Weekly Paclitaxel in Patients With Platinum Resistant/Refractory Ovarian Cancer Who Relapse During Bevacizumab Maintenance
-
CLINICAL_TRIALS study record update · 2023-08-31Drug Screening of Patient-derived Organoids From Ovarian Cancer Culture to Personalized Therapy,an Exploratory Research